SkinBioTherapeutics (SBTX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 14.25p
   
  • Change Today:
      0.000p
  • 52 Week High: 26.10p
  • 52 Week Low: 10.38p
  • Currency: UK Pounds
  • Shares Issued: 258.78m
  • Volume: 635,099
  • Market Cap: £36.88m

Latest ShareCast News

SkinBioTherapeutics revenue rises fourfold, still misses forecasts

By Josh White

Date: Thursday 14 Aug 2025

(Sharecast News) - SkinBioTherapeutics said in an update on Thursday that revenue for the year ended 30 June were expected to rise almost fourfold to between £4.5m and £4.8m, driven by a full-year contribution from Dermatonics, eight months from Bio-Tech Solutions (BTS), and continued organic growth in AxisBiotix sales.

SkinBioTherapeutics inks Superdrug deal, raises £4.1m

By Josh White

Date: Monday 16 Jun 2025

(Sharecast News) - SkinBioTherapeutics announced on Monday that it has signed an exclusive UK commercial agreement with Superdrug for its 'AxisBiotix' range of food supplements targeting inflammatory skin conditions, while also raising £4.1m through a placing and subscription to support the rollout and related operational needs.

SkinBioTherapeutics shares jump on acquisition of topical cream maker

By Benjamin Chiou

Date: Friday 11 Oct 2024

(Sharecast News) - AIM-listed life sciences company SkinBioTherapeutics has announced the acquisition of Yorkshire-based health, hygiene and personal care products group Bio-Tech Solutions for £1.25m.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

SBTX Market Data

Currency UK Pounds
Share Price 14.25p
Change Today 0.000p
% Change 0.00 %
52 Week High 26.10p
52 Week Low 10.38p
Volume 635,099
Shares Issued 258.78m
Market Cap £36.88m

SBTX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
71.12% below the market average71.12% below the market average71.12% below the market average71.12% below the market average71.12% below the market average
75.61% below the sector average75.61% below the sector average75.61% below the sector average75.61% below the sector average75.61% below the sector average
Price Trend
36.07% below the market average36.07% below the market average36.07% below the market average36.07% below the market average36.07% below the market average
9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average
Income Not Available
Growth
49.92% above the market average49.92% above the market average49.92% above the market average49.92% above the market average49.92% above the market average
72.41% above the sector average72.41% above the sector average72.41% above the sector average72.41% above the sector average72.41% above the sector average

SBTX Dividends

No dividends found

Trades for 28-Aug-2025

Time Volume / Share Price
16:30 38,425 @ 14.50p
15:54 38,425 @ 14.25p
14:33 24,827 @ 14.23p
14:31 35,620 @ 14.07p
14:04 140,374 @ 14.24p

SBTX Key Personnel

CEO Stuart Ashman
CFO Manprit Singh Randhawa

Top of Page